Low levels of human leukocyte antigen donor-specific antibodies detected by solid phase assay before transplantation are frequently clinically irrelevant

Terasaki, 2003, Humoral theory of transplantation, Am J Transplant, 3, 665, 10.1034/j.1600-6143.2003.00135.x Cai, 2005, Humoral theory of transplantation—mechanism, prevention, and treatment, Hum Immunol, 66, 334, 10.1016/j.humimm.2005.01.021 Terasaki, 2005, Humoral theory of transplantation: Further evidence, Curr Opin Immunol, 17, 541, 10.1016/j.coi.2005.07.018 Akalin, 2006, Sensitization after Kidney Transplantation, Clin J Am Soc Nephrol, 1, 433, 10.2215/CJN.01751105 Mao, 2007, Extremely high association between appearance of HLA antibodies and failure of kidney grafts in a five-year longitudinal study, Am J Transplant, 7, 864, 10.1111/j.1600-6143.2006.01711.x Lefaucheur, 2008, Clinical relevance of preformed HLA donor-specific antibodies in kidney transplantation, Am J Transplant, 8, 324, 10.1111/j.1600-6143.2007.02072.x Gupta, 2008, Pretransplant donor-specific antibodies in cytotoxic negative crossmatch kidney transplants: Are they relevant?, Transplantation, 85, 1200, 10.1097/TP.0b013e31816b1c37 van den Berg-Loonen, 2008, Clinical relevance of pretransplant donor-directed antibodies detected by single antigen beads in highly sensitized renal transplant patients, Transplantation, 85, 1086, 10.1097/TP.0b013e31816b3ed1 Patel, 2007, Renal transplantation in patients with pretransplantation donor-specific antibodies and negative flow cytometry crossmatches, Am J Transplant, 7, 2371, 10.1111/j.1600-6143.2007.01944.x Manuel, 2007, Efficacy and safety of universal valganciclovir prophylaxis combined with a tacrolimus/mycophenolate-based regimen in kidney transplantation, Swiss Med Weekly, 137, 669 Gebel, 2003, Pre-transplant assessment of donor-reactive, HLA-specific antibodies in renal transplantation: Contraindication vs. risk, Am J Transplant, 3, 1488, 10.1046/j.1600-6135.2003.00273.x Billen, 2009, Donor-directed HLA antibodies before and after transplantectomy detected by the Luminex single antigen assay, Transplantation, 87, 563, 10.1097/TP.0b013e3181949e37 Higgins, 2007, Blood levels of donor-specific human leukocyte antigen antibodies after renal transplantation: Resolution of rejection in the presence of circulating donor-specific antibody, Transplantation, 84, 876, 10.1097/01.tp.0000284729.39137.6e Billen, 2008, Luminex donor-specific crossmatches, Tissue Antigens, 71, 507, 10.1111/j.1399-0039.2008.01032.x Gibney, 2006, Detection of donor-specific antibodies using HLA-coated microspheres: Another tool for kidney transplant risk stratification, Nephrol Dial Transplant, 21, 2625, 10.1093/ndt/gfl202 Pollinger, 2007, Kidney transplantation in patients with antibodies against donor HLA class II, Am J Transplant, 7, 857, 10.1111/j.1600-6143.2006.01699.x Süsal, 2004, Good kidney transplant outcome in recipients with presensitization against HLA class II but not HLA class I, Hum Immunol, 65, 810, 10.1016/j.humimm.2004.05.010 Akalin, 2008, Addition of plasmapheresis decreases the incidence of acute antibody-mediated rejection in sensitized patients with strong donor-specific antibodies, Clin J Am Soc Nephrol, 3, 1160, 10.2215/CJN.05321107 Mizutani, 2007, The importance of anti-HLA-specific antibody strength in monitoring kidney transplant patients, Am J Transplant, 7, 1027, 10.1111/j.1600-6143.2006.01721.x Mai, 2009, Excellent renal allograft survival in donor-specific antibody positive transplant patients—role of intravenous immunoglobulin and rabbit antithymocyte globulin, Transplantation, 87, 227, 10.1097/TP.0b013e31818c962b